摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2RS,3RS)-2-hydroxy-4-phenyl-3-(phenylcarbonyl)amino-1,1,1-trifluorobutane | 123206-12-2

中文名称
——
中文别名
——
英文名称
(2RS,3RS)-2-hydroxy-4-phenyl-3-(phenylcarbonyl)amino-1,1,1-trifluorobutane
英文别名
N-[3,3,3-trifluoro-2-hydroxy-1-(phenylmethyl)propyl]benzamide;1,1,1-trifluoro-3-benzoylamino-4-phenyl-2-butanol;(2RS,3RS)-3-Benzoylamino-2-hydroxy-4-phenyl-1,1,1-trifluorobutane;N-(4,4,4-trifluoro-3-hydroxy-1-phenylbutan-2-yl)benzamide
(2RS,3RS)-2-hydroxy-4-phenyl-3-(phenylcarbonyl)amino-1,1,1-trifluorobutane化学式
CAS
123206-12-2
化学式
C17H16F3NO2
mdl
——
分子量
323.315
InChiKey
YSTOGOUISZLEJD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    522.5±50.0 °C(Predicted)
  • 密度:
    1.269±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    23
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.24
  • 拓扑面积:
    49.3
  • 氢给体数:
    2
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Inhibitors of Cathepsin G and elastase for preventing connective tissue
    申请人:Merrell Pharmaceuticals Inc.
    公开号:US05510333A1
    公开(公告)日:1996-04-23
    Novel compounds which are chemically linked inhibitors of the proteases Elastase and Cathepsin G prevent connective tissue degradation associated with neutrophil induced inflammatory disease.
    新化合物,它们是与蛋白酶弹性蛋白酶和猫hepsin G化学连接的抑制剂,可以预防与中性粒细胞诱导的炎症性疾病相关的结缔组织降解。
  • Novel thiazine derivatives
    申请人:SANTEN PHARMACEUTICAL CO.,LTD.
    公开号:US20040097496A1
    公开(公告)日:2004-05-20
    A compound having 3-oxo-3,4-dihydro-2H-1,4-thiazine 4-tetrahydropyrazine as a main skeleton. The compound is a chymase inhibitor and is represented by the following formula [I] and salts thereof: 1 In the formula [I], X is S; R 1 and R 2 are H, alkyl, cycloalkyl or aryl; R 3 and R 4 are H, alkyl, cycloalkyl, aryl or an aromatic heterocycle; R 5 is H, alkyl, cycloalkyl, aryl or -A 3 -A 4 -R 7 ; R 6 is H, alkyl, cycloalkyl, hydroxy, alkoxy, aryl, aryloxy or an aromatic heterocycle; R 7 is H, alkyl, hydroxy, alkoxy, aryl, aryloxy, amino, alkylamino, arylamino, an aromatic heterocycle or a nonaromatic heterocycle; A 1 is alkylene; A 2 is carbonyl or sulfonyl; A 3 is alkylene; A 4 is carbonyl or oxalyl; and n is 0 or 1.
    化合物具有3-氧代-3,4-二氢-2H-1,4-噻嗪-4-四氢吡嗪作为主要骨架。该化合物是一种Chymase抑制剂,由以下公式[I]及其盐所表示:1在公式[I]中,X为S;R1和R2为H,烷基,环烷基或芳基;R3和R4为H,烷基,环烷基,芳基或芳香族杂环;R5为H,烷基,环烷基,芳基或-A3-A4-R7;R6为H,烷基,环烷基,羟基,烷氧基,芳基,芳氧基或芳香族杂环;R7为H,烷基,羟基,烷氧基,芳基,芳氧基,氨基,烷基氨基,芳基氨基,芳香族杂环或非芳香族杂环;A1为烷基;A2为羰基或磺酰基;A3为烷基;A4为羰基或草酰基;n为0或1。
  • Thiazine derivatives
    申请人:Nishimura Kazuo
    公开号:US06960575B2
    公开(公告)日:2005-11-01
    A compound having 3-oxo-3, 4-dihydro-2H-1, 4-thiazine 4-tetrahydropyrazine as a main skeleton. The compound is a chymase inhibitor and is represented by the following formula [I] and salts thereof: In the formula [I], X is S; R 1 and R 2 are H, alkyl, cycloalkyl or aryl; R 3 and R 4 are H, alkyl, cycloalkyl, aryl or an aromatic heterocycle; R 5 is H, alkyl, cycloalkyl, aryl or -A 3 -A 4 -R 7 ; R 6 is H, alkyl, cycloalkyl, hydroxy, alkoxy, aryl, aryloxy or an aromatic heterocycle; R 7 is H, alkyl, hydroxy, alkoxy, aryl, aryloxy, amino, alkylamino, arylamino, an aromatic heterocycle or a nonaromatic heterocycle; A 1 is alkylene; A 2 is carbonyl or sulfonyl; A 3 is alkylene; A 4 is carbonyl or oxalyl; and n is 0 or 1.
    一种具有3-氧代-3,4-二氢-2H-1,4-噻嗪-4-四氢吡嗪为主要骨架的化合物。该化合物是一种胰蛋白酶酶抑制剂,其化学式[I]及其盐如下所示:在公式[I]中,X为S;R1和R2为H,烷基,环烷基或芳基;R3和R4为H,烷基,环烷基,芳基或芳香族杂环;R5为H,烷基,环烷基,芳基或-A3-A4-R7;R6为H,烷基,环烷基,羟基,烷氧基,芳基,芳氧基或芳香族杂环;R7为H,烷基,羟基,烷氧基,芳基,芳氧基,氨基,烷基氨基,芳基氨基,芳香族杂环或非芳香族杂环;A1为烷基;A2为羰基或磺酰基;A3为烷基;A4为羰基或草酰基;n为0或1。
  • HETEROCYCLIC AMIDE COMPOUNDS AND MEDICINAL USE OF THE SAME
    申请人:THE GREEN CROSS CORPORATION
    公开号:EP0826671A1
    公开(公告)日:1998-03-04
    Heterocyclic amide compounds of the formula (I) wherein each symbol is as defined in the specification, pharmacologically acceptable salts thereof, pharmaceutical compositions thereof and pharmaceutical use thereof. The heterocyclic amide compounds and pharmacologically acceptable salts thereof of the present invention have superior inhibitory activity against chymase groups in mammals inclusive of human, and can be administered orally or parenterally. Therefore, they are useful as chymase inhibitors and can be effective for the prophylaxis and treatment of various diseases caused by chymase, such as those caused by angiotensin II.
    式 (I) 的杂环酰胺化合物 其中各符号如说明书中所定义,其药理上可接受的盐、其药物组合物和其药物用途。本发明的杂环酰胺化合物及其药理学上可接受的盐类对哺乳动物(包括人类)的糜蛋白酶基团具有优异的抑制活性,并且可以口服或肠外给药。因此,它们可作为糜蛋白酶抑制剂,有效预防和治疗由糜蛋白酶引起的各种疾病,如血管紧张素 II 引起的疾病。
  • NOVEL THIAZOLIDINE DERIVATIVES
    申请人:SANTEN PHARMACEUTICAL CO., LTD.
    公开号:EP1103560A1
    公开(公告)日:2001-05-30
    An object of the present invention is to provide novel thiazolidine derivatives which are useful as drugs. The thiazolidine derivatives according to the present invention are compounds represented by the following general formula [I] and salts thereof, wherein R1 is alkyl, hydroxy, alkoxy, alkoxyalkyl, phenyl, phenylalkyl, phenylalkoxy, phenoxy, phenoxyalkyl, amino, alkylamino or a nonaromatic heterocycle; R2 is H or alkyl; R3 is H, alkyl or phenyl; R4 is H or alkyl; R5 is alkyl, halogenoalkyl, hydroxy, alkoxy, phenyl, phenylalkoxy, phenoxy, carboxyl, alkoxycarbonyl, phenylalkoxycarbonyl or an aromatic heterocycle; A1 is alkylene; and A2 is alkylene.
    本发明的目的是提供可用作药物的新型噻唑烷衍生物。根据本发明的噻唑烷衍生物是由以下通式[I]代表的化合物及其盐类、 其中 R1 是烷基、羟基、烷氧基、烷氧基烷基、苯基、苯基烷基、苯基烷氧基、苯氧基、苯氧基烷基、氨基、烷基氨基或非芳香杂环;R2 是 H 或烷基;R3 是 H、烷基或苯基;R4 是 H 或烷基;R5 是烷基、卤代烷基、羟基、烷氧基、苯基、苯基烷氧基、苯氧基、羧基、烷氧基羰基、苯基烷氧基羰基或芳香杂环;A1 是亚烷基;A2 是亚烷基。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐